Bacillus subtilis VSG4 produces lipopeptide-type biosurfactant as a secondary metabolite.
Administration of biosurfactant led to enhanced immunity in Labeo rohita.
The biosurfactant altered cytokine-related gene expression in the head kidney.
Biosurfactant administration led to higher post-challenge survival rates.